Women identified as BRCA1 and BRCA2 mutation carriers are advised to manage their cancer risk through intensive screening programs and/or by undergoing risk-reducing surgery. The aim of this study was to explore and describe the experiences of female BRCA1/2 mutation carriers living with cancer risk and their experiences with participation in educational support groups (ESG). This qualitative study enrolled 17 (10 + 7) ESG participants in two different ESGs. The focus group interviews were performed immediately prior to and following two ESGs. The data were analyzed using John Knodel’s (1993) practical approach. Three main themes were identified; the women’s expectation and experience with ESG, the feeling of loneliness and isolation, and the feelings of living with “something else.” In this paper we have focused on one of the main themes- the women’s expectation and experience with ESG. This main theme presents four subthemes: the women’s need for unambiguous, clear and unified information from health professionals, the need for social support, the important role of the patient representative, and increased knowledge potentially raising concern. Participation in an ESG for women with BRCA1 and BRCA2 mutations can provide relevant information and support in the decision-making process related to risk-reducing surgery.
This is a preview of subscription content, access via your institution.
Antonovsky, A. (1979). Health, stress, and coping. San Francisco, CA: Jossey-Bass.
Antonovsky, A. (1987). Unraveling the mystery of health: how people manage stress and stay well. San Francisco, CA: Jossey-Bass.
Aujoulat, I., d’Hoore, W., & Deccache, A. (2007). Patient Empowerment in Theory and Practice: Polysemy or Cacophony? Patient Education and Counseling, 66(1), 13–20.
Austvoll-Dahlgren, A., Nøstberg, A. M., Steinsbekk, A., & Vist, G. E. (2011). The effects of group education on patients and their next of kin (Vol. nr 09–2011). Oslo: Norwegian Knowledge Centre for the Health Services.
Bermejo-Perez, M. J., Marquez-Calderon, S., & Llanos-Mendez, A. (2007). Effectiveness of Preventive Interventions in BRCA1/2 Gene Mutation Carriers: a Systematic Review. International Journal of Cancer, 121(2), 225–231.
Blackwood, M. A., & Weber, B. L. (1998). BRCA1 and BRCA2: from Molecular Genetics to Clinical Medicine. Journal of Clinical Oncology, 16(5), 1969–1977.
Bosch, N., Junyent, N., Gadea, N., Brunet, J., T., R. y. C.,., Torres, A., et al. (2012). What Factors may Influence Psychological well Being at three Months and one Year Post BRCA Genetic Result Disclosure? Breast, 21(6), 755–760.
Bresser, P. J., Seynaeve, C., Van Gool, A. R., Niermeijer, M. F., Duivenvoorden, H. J., van Dooren, S., et al. (2007). The Course of Distress in Women at Increased Risk of Breast and Ovarian Cancer Due to an (Identified) Genetic Susceptibility Who Opt for Prophylactic Mastectomy and/or Salpingo-Oophorectomy. European Journal of Cancer, 43(1), 95–103.
Crawford, M. J., Rutter, D., Manley, C., Weaver, T., Bhui, K., Fulop, N., et al. (2002). Systematic Review of Involving Patients in the Planning and Development of Health Care. BMJ, 325(7375), 1263.
den Heijer, M., Seynaeve, C., Vanheusden, K., Duivenvoorden, H. J., Bartels, C. C., Menke-Pluymers, M. B., et al. (2011). Psychological Distress in Women at Risk for Hereditary Breast Cancer: the Role of Family Communication and Perceived Social Support. Psychooncology, 20(12), 1317–1323.
Di Prospero, L. S., Seminsky, M., Honeyford, J., Doan, B., Franssen, E., Meschino, W., et al. (2001). Psychosocial Issues Following a Positive Result of Genetic Testing for BRCA1 and BRCA2 Mutations: Findings from a Focus Group and a Needs-Assessment Survey. Canadian Medical Association Journal, 164(7), 1005–1009.
Domchek, S. M., Friebel, T. M., Singer, C. F., Evans, D. G., Lynch, H. T., Isaacs, C., et al. (2010). Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers with Cancer Risk and Mortality. Journal of the American Medical Association, 304(9), 967–975.
Dorval, M., Bouchard, K., Chiquette, J., Glendon, G., Maugard, C. M., Dubuisson, W., et al. (2013). A Focus Group Study on Breast Cancer Risk Presentation: one Format Does not Fit all. European Journal of Human Genetics, 21(7), 719–724.
Douglas, H. A., Hamilton, R. J., & Grubs, R. E. (2009). The Effect of BRCA Gene Testing on Family Relationships: A Thematic Analysis of Qualitative Interviews. Journal of Genetic Counseling, 18(5), 418–435.
Edwards, A., Gray, J., Clarke, A., Dundon, J., Elwyn, G., Gaff, C., et al. (2008). Interventions to Improve Risk Communication in Clinical Genetics: Systematic Review. Patient Education and Counseling, 71(1), 4–25.
Eisen, A., Lubinski, J., Klijn, J., Moller, P., Lynch, H. T., Offit, K., et al. (2005). Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: an International Case-Control Study. Journal of Clinical Oncology, 23(30), 7491–7496.
Esplen, M. J., Hunter, J., Leszcz, M., Warner, E., Narod, S., Metcalfe, K., et al. (2004). A Multicenter Study of Supportive-Expressive Group Therapy for Women with BRCA1/BRCA2 Mutations. Cancer, 101(10), 2327–2340.
Finch, A. P., Lubinski, J., Moller, P., Singer, C. F., Karlan, B., Senter, L., et al. (2014). Impact of Oophorectomy on Cancer Incidence and Mortality in Women with a BRCA1 or BRCA2 Mutation. Journal of Clinical Oncology, 32(15), 1547–1553.
Garber, J. E., & Offit, K. (2005). Hereditary Cancer Predisposition Syndromes. Journal of Clinical Oncology, 23(2), 276–292.
Geirdal, A. O., Reichelt, J. G., Dahl, A. A., Heimdal, K., Maehle, L., Stormorken, A., et al. (2005). Psychological Distress in Women at Risk of Hereditary Breast/Ovarian or HNPCC Cancers in the Absence of Demonstrated Mutations. Familial Cancer, 4(2), 121–126.
Hallowell, N., Baylock, B., Heiniger, L., Butow, P. N., Patel, D., Meiser, B., et al. (2012). Looking Different, Feeling Different: women’s Reactions to Risk-Reducing Breast and Ovarian Surgery. Familial Cancer, 11(2), 215–224.
Howard, A. F., Balneaves, L. G., Bottorff, J. L., & Rodney, P. (2011). Preserving the Self: the Process of Decision Making about Hereditary Breast Cancer and Ovarian Cancer Risk Reduction. Qualitative Health Research, 21(4), 502–519.
Hvas, A. C., & Thesen, J. (2002). To Strengthen patient’s Own Power and to Counteract Oppressive Forces: Empowerment in a Medical Perspective. Ugeskrift for Laeger, 164(46), 5361–5365.
Jeffers, L., Morrison, P. J., McCaughan, E., & Fitzsimons, D. (2014). Maximising Survival: the Main Concern of Women with Hereditary Breast and Ovarian Cancer Who Undergo Genetic Testing for BRCA1/2. European Journal of Oncology Nursing, 18(4), 411–418.
Kauff, N. D., Domchek, S. M., Friebel, T. M., Robson, M. E., Lee, J., Garber, J. E., et al. (2008). Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: a Multicenter, Prospective Study. Journal of Clinical Oncology, 26(8), 1331–1337.
Kvale, K. (2007). Do Cancer Patients always Want to Talk about Difficult Emotions? A Qualitative Study of Cancer Inpatients Communication Needs. European Journal of Oncology Nursing, 11(4), 320–327.
Kvale, S. (1996). Interviews: an introduction to qualitative research interviewing. Thousand Oaks, CA: Sage.
Landsbergen, K. M., Brunner, H. G., Manders, P., Hoogerbrugge, N., & Prins, J. B. (2010). Educational-Support Groups for BRCA Mutation Carriers Satisfy Need for Information but Do not Affect Emotional Distress. Genetic Counseling, 21(4), 423–437.
Langeland, E., & Wahl, A. K. (2009). The Impact of Social Support on Mental Health Service Users’ Sense of Coherence: a Longitudinal Panel Survey. International Journal of Nursing Studies, 46(6), 830–837.
Langeland, E., Wahl, A. K., Kristoffersen, K., & Hanestad, B. R. (2007). Promoting Coping: Salutogenesis among People with Mental Health Problems. Issues in Mental Health Nursing, 28(3), 275–295.
Lindström, B., & Eriksson, M. (2010). The hitchhiker’s guide to salutogenesis: salutogenic pathways to health promotion. Folkhälsan: Helsinki.
Lodder, L. N., Frets, P. G., Trijsburg, R. W., Meijers-Heijboer, E. J., Klijn, J. G., Seynaeve, C., et al. (2002). One Year Follow-Up of Women Opting for Presymptomatic Testing for BRCA1 and BRCA2: Emotional Impact of the Test Outcome and Decisions on Risk Management (Surveillance or Prophylactic Surgery). Breast Cancer Research and Treatment, 73(2), 97–112.
Lux, M. P., Fasching, P. A., & Beckmann, M. W. (2006). Hereditary Breast and Ovarian Cancer: Review and Future Perspectives. Journal of Molecular Medicine (Berlin, Germany), 84(1), 16–28.
MacDonald, D. J., Sarna, L., Weitzel, J. N., & Ferrell, B. (2010). Women’s Perceptions of the Personal and Family Impact of Genetic Cancer Risk Assessment: Focus Group Findings. Journal of Genetic Counseling, 19(2), 148–160.
Madalinska, J. B., van Beurden, M., Bleiker, E. M., Valdimarsdottir, H. B., Hollenstein, J., Massuger, L. F., et al. (2006). The Impact of Hormone Replacement Therapy on Menopausal Symptoms in Younger High-Risk Women after Prophylactic Salpingo-Oophorectomy. Journal of Clinical Oncology, 24(22), 3576–3582.
McCullum, M., Bottorff, J. L., Kelly, M., Kieffer, S. A., & Balneaves, L. G. (2007). Time to Decide about Risk-Reducing Mastectomy: a Case Series of BRCA1/2 Gene Mutation Carriers. BMC Womens Health, 7, 3.
Meindl, A., Ditsch, N., Kast, K., Rhiem, K., & Schmutzler, R. K. (2011). Hereditary Breast and Ovarian Cancer: New Genes, New Treatments, New Concepts. Deutsches Ärzteblatt International, 108(19), 323–330.
Moller, P., Stormorken, A., Jonsrud, C., Holmen, M. M., Hagen, A. I., Clark, N., et al. (2013). Survival of Patients with BRCA1-Associated Breast Cancer Diagnosed in an MRI-Based Surveillance Program. Breast Cancer Research and Treatment, 139(1), 155–161.
Morgan, D. L. (1993). Successful focus groups: advancing the state of the art. Newbury Park, CA: Sage.
NKLMS (The Norwegian National Advisory Unit on Learning and Mastery in Health). (2013). Retrieved from http://mestring.no/in-english/
Norwegian Breast Cancer Group. (2011). Retrieved from http://www.nbcg.no/index.html
Patenaude, A. F., Orozco, S., Li, X., Kaelin, C. M., Gadd, M., Matory, Y., et al. (2008). Support Needs and Acceptability of Psychological and Peer Consultation: Attitudes of 108 Women Who Had Undergone or Were Considering Prophylactic Mastectomy. Psychooncology, 17(8), 831–843.
Rebbeck, T. R., Kauff, N. D., & Domchek, S. M. (2009). Meta-Analysis of Risk Reduction Estimates Associated with Risk-Reducing Salpingo-Oophorectomy in BRCA1 or BRCA2 Mutation Carriers. Journal of the National Cancer Institute, 101(2), 80–87.
Rosas-Blum, E., Shirsat, P., & Leiner, M. (2007). Communicating Genetic Information: a Difficult Challenge for Future Pediatricians. BMC Medical Education, 7, 17.
Salhab, M., Bismohun, S., & Mokbel, K. (2010). Risk-Reducing Strategies for Women Carrying BRCA1/2 Mutations with a Focus on Prophylactic Surgery. BMC Womens Health, 10, 28.
Skytte, A. B., Cruger, D., Gerster, M., Laenkholm, A. V., Lang, C., Brondum-Nielsen, K., et al. (2011). Breast Cancer after Bilateral Risk-Reducing Mastectomy. Clinical Genetics, 79(5), 431–437.
Visser, A., Prins, J. B., Hoogerbrugge, N., & van Laarhoven, H. W. (2011). Group Medical Visits in the Follow-Up of Women with a BRCA Mutation: Design of a Randomized Controlled Trial. BMC Womens Health, 11, 39.
Wainberg, S., & Husted, J. (2004). Utilization of Screening and Preventive Surgery among Unaffected Carriers of a BRCA1 or BRCA2 Gene Mutation. Cancer Epidemiology, Biomarkers & Prevention, 13(12), 1989–1995.
Werner-Lin, A. (2008). Formal and Informal Support Needs of Young Women with BRCA Mutations. Journal of Psychosocial Oncology, 26(4), 111–133.
We thank the research participants for sharing their time and insight during this study. This research was supported by practical support by the Department of Medical Genetics, University Hospital of North—Norway.
Conflict of Interest
Marion Myklebust, Eva Gjengedal and Nina Strømsvik declare that they have no conflict of interest.
Human Studies and Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.
About this article
Cite this article
Myklebust, M., Gjengedal, E. & Strømsvik, N. Experience of Norwegian Female BRCA1 and BRCA2 Mutation-Carrying Participants in Educational Support Groups: a Qualitative Study. J Genet Counsel 25, 1198–1206 (2016). https://doi.org/10.1007/s10897-016-9954-9
- Hereditary cancers
- Educational support group
- Risk-reducing mastectomy
- Risk-reducing oophorectomy